Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

Chemotherapy: Open Access : Citations & Metrics Report

Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Total published articles

26 36 28 30 8 0 17 24 52 34 23 18 27

Research, Review articles and Editorials

0 9 7 20 5 0 13 17 22 18 18 16 27

Research communications, Review communications, Editorial communications, Case reports and Commentary

14 26 21 5 3 0 4 7 24 14 4 2 0

Conference proceedings

0 0 0 0 0 0 0 0 0 28 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

36 53 100 85 112 83 142 208 141 51 22 53 3
Journal total citations count 709
Journal impact factor 1.81
Journal 5 years impact factor 3.80
Journal cite score 4.89
Journal h-index 12
Journal h-index since 2019 9
Important citations (402)

costello lc, franklin rb (2017) decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. expert opinion on therapeutic targets 21: 51-66.

dezortova m, jiru f, skoch a, capek v, ryznarova z, et al. (2016) the aging effect on prostate metabolite concentrations measured by 1h mr spectroscopy. magnetic resonance materials in physics, biology and medicine 13: 1-0.

vella v, malaguarnera r, lappano r, maggiolini m, belfiore a, et al. (2016) recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer. molecular and cellular endocrinology 20.

denoyer d, pearson hb, clatworthy sa, smith zm, francis ps, et al. (2016) copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. oncotarget 7: 37064.

costello lc, zou j, franklin rb (2016) in situ clinical evidence that zinc levels are decreased in breast invasive ductal carcinoma. cancer causes & control 27: 729-35.

septiawan ad, kodariah r, saraswati m (2016) analysis expression of zip1 and caspase-3 protein in adenocarsinoma of the prostate. makara journal of health research 13:18-22.

costello lc, franklin rb (2016) a comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. archives of biochemistry and biophysics 611: 100-12.

franklin rb, zou j, zheng y, naslund mj, costello lc, et al. (2016) zinc ionophore (clioquinol) inhibition of human zip1-deficient prostate tumor growth in the mouse ectopic xenograft model: a zinc approach for the efficacious treatment of prostate cancer. international journal of cancer and clinical research 3: 37.

mounika m (2016) review on: adverse drug reactions of chemotherapy drugs. review on: adverse drug reactions of chemotherapy drugs. research & reviews: journal of pharmacology and toxicological studies 4: 1-9.

surai pf (2015) antioxidant systems in poultry biology: heat shock proteins. journal of science 5: 1188-1222.

thakur, chetna (2016) gene therapy for cancer treatment.research & reviews: journal of medical and health sciences 5: 1-5.

sunaree c (2015) gene cloning and characterization of mreb and ftsz from bacillus subtilis.

lopes ed, oliveira cg, silva pb, eismann ce, suárez ca, et al. (2016) novel zinc (ii) complexes [zn (atc-et) 2] and [zn (atc-ph) 2]: in vitro and in vivo antiproliferative studies. international journal of molecular sciences 17: 781.

zagorac s, alcala s, bayon gf, kheir tb, schoenhals m, et al. (2016) dnmt1 inhibition reprograms pancreatic cancer stem cells via upregulation of the mir-17-92 cluster. cancer research 76: 4546-4558.

valenzuela mm, castro i, gonda a, osterman cj, jutzy jm, et al. (2015) cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase. oncotargets and therapy 8: 495.

schultz a, qutub aa (2016) reconstruction of tissue-specific metabolic networks using corda. plos comput biol 12: e1004808.

Choi sy, lee hh, lee jh, ye bj, yoo ej, et al. (2016) tonebp suppresses il-10-mediated immunomodulation. scientific reports 6: 25726.

diac ap, Å¢epeÅŸ am, soran a, grosu i, terec a, et al. (2016) indenopyrans–synthesis and photoluminescence properties. beilstein journal of organic chemistry 12: 825-834.

ma j, lim c, sacher jr, van houten b, qian w, et al. (2015) mitochondrial targeted β-lapachone induces mitochondrial dysfunction and catastrophic vacuolization in cancer cells. bioorganic & medicinal chemistry letters 25: 4828-4833.

lee ej, ko hm, jeong yh, park em, kim hs, et al. (2015) β-lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. journal of neuroinflammation 12: 133.

Top